✦ LIBER ✦

A prospective, double-blind, community-controlled comparison of three doses of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population

✍ Scribed by Guk-Hee Suh; Hee Yeon Jung; Chang Uk Lee; Byoung Hoon Oh; Jae Nam Bae; Han-Yong Jung; Young-Su Ju; Byeong Kil Yeon; JongHan Park; InJa Hong; Sungku Choi; Jung Ho Lee

Book ID: 116371678
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 877 KB
Volume: 26
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2004.10.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous immunoglobulin for treatment

Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial

✍ Dodel, Richard; Rominger, Axel; Bartenstein, Peter; Barkhof, Frederik; Blennow, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 746 KB

A 22-week, multicenter, randomized, doub

A 22-week, multicenter, randomized, double-blind controlled trial ofCrocus sativusin the treatment of mild-to-moderate Alzheimer’s disease

✍ Shahin Akhondzadeh; Mehdi Shafiee Sabet; Mohammad Hossein Harirchian; Mansoreh T 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 161 KB

A 24-week, double-blind, placebo-control

A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease

✍ X. A. Alvarez; R. Cacabelos; M. Laredo; V. Couceiro; C. Sampedro; M. Varela; L. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

Melissa officinalis extract in the treat

Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial

✍ Akhondzadeh, S 📂 Article 📅 2003 🏛 BMJ Publishing Group 🌐 English ⚖ 224 KB

Safety and efficacy of a galantamine/mem

Safety and efficacy of a galantamine/memantine combination in mild to moderate Alzheimer's disease - randomized controlled trial

✍ Oliver Peters; Wolfgang Maier; Christian Luckhaus; Johannes Kornhuber; Johannes 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Study of the ketogenic agent AC-1202 in

Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial

✍ Samuel T Henderson; Janet L Vogel; Linda J Barr; Fiona Garvin; Julie J Jones; La 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 640 KB